Literature DB >> 24785779

Cross-sectional study of unexplained white matter lesions in HIV positive individuals undergoing brain magnetic resonance imaging.

Lewis J Haddow1, Cristina Dudau, Hoskote Chandrashekar, Jonathan D Cartledge, Harpreet Hyare, Robert F Miller, H Rolf Jäger.   

Abstract

White matter (WM) abnormalities are frequently seen on brain MRI of HIV positive (HIV+) patients. We aimed to determine the prevalence of unexplained WM abnormalities and their associations with HIV disease and cardiovascular risk factors. We conducted a retrospective, cross-sectional study of brain MRI of HIV+ patients conducted between 2004 and 2009 at our center. Clinical and laboratory data were compiled, and images were independently reviewed for WM lesions. Images were obtained from 254 patients: 70% male, 53% white, 40% black, mean age 42 years, median current CD4 count 240 cells/mm(3), and 41% not taking antiretroviral therapy (ART). Hyperintense WM lesions were present in 161 patients (63.4%): 89 scans (35.0%) showed diffuse WM signal abnormality (DWMSA), 61 (24.0%) were consistent with small vessel disease (SVD, graded by Fazekas' scale), and 37 (14.6%) showed large asymmetrical focal WM lesions. SVD changes were associated with age and cardiovascular risk factors, and while cerebral SVD may be related to HIV infection, the MRI findings were not associated with HIV-related factors. The only risk factor for DWMSA was black race, and no correlation with cardiovascular risk factors, CD4 count, or clinical presentation was identified. DWMSA are therefore of uncertain neurological significance in HIV+ patients and could represent more than one clinicopathological entity.

Entities:  

Mesh:

Year:  2014        PMID: 24785779      PMCID: PMC4074759          DOI: 10.1089/apc.2013.0230

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  46 in total

1.  Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy.

Authors:  M Depairon; S Chessex; P Sudre; N Rodondi; N Doser; J P Chave; W Riesen; P Nicod; R Darioli; A Telenti; V Mooser
Journal:  AIDS       Date:  2001-02-16       Impact factor: 4.177

2.  Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV.

Authors:  C C Cloak; L Chang; T Ernst
Journal:  J Neuroimmunol       Date:  2004-12       Impact factor: 3.478

3.  Incidental white matter hyperintensities on magnetic resonance imaging in HIV-1 infection. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; A J Kumar; D W Johnson; O A Selnes; J T Becker; C Herman; B A Cohen; A Saah
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

4.  Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

Authors:  Lucette A Cysique; Paul Maruff; Bruce J Brew
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

5.  Magnetic resonance imaging of white matter lesions in HIV infection.

Authors:  R A Bornstein; D Chakeres; M Brogan; H A Nasrallah; R J Fass; M Para; C Whitacre
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

6.  Focal brain lesions in patients with AIDS: aetiologies and corresponding radiological patterns in a prospective study.

Authors:  H Steinmetz; G Arendt; H Hefter; E Neuen-Jacob; K Dörries; A Aulich; T Kahn
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

7.  Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history.

Authors:  Carole Dufouil; Ophélia Godin; John Chalmers; Oghuzan Coskun; Stephen MacMahon; Nathalie Tzourio-Mazoyer; Marie-Germaine Bousser; Craig Anderson; Bernard Mazoyer; Christophe Tzourio
Journal:  Stroke       Date:  2009-04-23       Impact factor: 7.914

8.  Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.

Authors:  David J Werring; Duncan W Frazer; Lucy J Coward; Nick A Losseff; Hilary Watt; Lisa Cipolotti; Martin M Brown; H Rolf Jäger
Journal:  Brain       Date:  2004-07-28       Impact factor: 13.501

9.  Serial MRI of the brain in asymptomatic patients infected with HIV: results from the UCMSM/Medical Research Council neurology cohort.

Authors:  H Manji; S Connolly; R McAllister; A R Valentine; B E Kendall; M Fell; P Durrance; A J Thompson; S Newman; I V Weller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-02       Impact factor: 10.154

10.  Neurosyphilis in HIV-positive and HIV-negative patients: neuroimaging findings.

Authors:  T C Brightbill; I H Ihmeidan; M J Post; J R Berger; D A Katz
Journal:  AJNR Am J Neuroradiol       Date:  1995-04       Impact factor: 3.825

View more
  10 in total

1.  White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV.

Authors:  Christa Watson; Edgar Busovaca; Jessica M Foley; I Elaine Allen; Christopher G Schwarz; Neda Jahanshad; Talia M Nir; Pardis Esmaeili-Firidouni; Benedetta Milanini; Howard Rosen; Owen T Carmichael; Paul M Thompson; Victor G Valcour
Journal:  J Neurovirol       Date:  2017-01-18       Impact factor: 2.643

Review 2.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study.

Authors:  Benedetta Milanini; Stephanie Catella; Brandon Perkovich; Pardis Esmaeili-Firidouni; Lauren Wendelken; Robert Paul; Meredith Greene; Robin Ketelle; Victor Valcour
Journal:  AIDS Care       Date:  2017-01-27

4.  HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.

Authors:  Ryan Sanford; Jeremy Strain; Mahsa Dadar; Josefina Maranzano; Alexandre Bonnet; Nancy E Mayo; Susan C Scott; Lesley K Fellows; Beau M Ances; D Louis Collins
Journal:  AIDS       Date:  2019-06-01       Impact factor: 4.177

5.  Neural response to working memory demand predicts neurocognitive deficits in HIV.

Authors:  Ronald A Cohen; S Siegel; J M Gullett; E Porges; A J Woods; H Huang; Y Zhu; K Tashima; M-Z Ding
Journal:  J Neurovirol       Date:  2017-12-26       Impact factor: 3.739

Review 6.  The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.

Authors:  Natalie M Zahr
Journal:  Front Aging Neurosci       Date:  2018-03-22       Impact factor: 5.750

7.  Correlates of telomere length shortening in peripheral leukocytes of HIV-infected individuals and association with leukoaraiosis.

Authors:  Rumi Minami; Soichiro Takahama; Masahiro Yamamoto
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

8.  Pathomechanisms of HIV-Associated Cerebral Small Vessel Disease: A Comprehensive Clinical and Neuroimaging Protocol and Analysis Pipeline.

Authors:  Kyle D Murray; Meera V Singh; Yuchuan Zhuang; Md Nasir Uddin; Xing Qiu; Miriam T Weber; Madalina E Tivarus; Henry Z Wang; Bogachan Sahin; Jianhui Zhong; Sanjay B Maggirwar; Giovanni Schifitto
Journal:  Front Neurol       Date:  2020-12-15       Impact factor: 4.003

9.  Differences in location of cerebral white matter hyperintensities in children and adults living with a treated HIV infection: A retrospective cohort comparison.

Authors:  Jason G van Genderen; Malon Van den Hof; Anders C Boyd; Matthan W A Caan; Ferdinand W N M Wit; Peter Reiss; Dasja Pajkrt
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

10.  Human immunodeficiency virus-related decreases in corpus callosal integrity and corresponding increases in functional connectivity.

Authors:  Shana A Hall; Ryan P Bell; Simon W Davis; Sheri L Towe; Taylor P Ikner; Christina S Meade
Journal:  Hum Brain Mapp       Date:  2021-08-12       Impact factor: 5.038

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.